Use of banned superdrol as ingredient means Uprizing 2.0 now gone from market

(Oct. 12, 2011) – A nutritional supplement in capsule form used by bodybuilders as an aid to increasing muscle mass has been pulled from shelves after the U.S. Food & Drug Administration found the product contained a banned synthetic anabolic steroid, superdrol.

Uprizing 2.0 maker Superior Metabolic Technologies in August received a letter of notification from the FDA informing the Marietta, Ga., company of the formulation problem.

Superior Metabolic Technologies responded by voluntarily removing superdrol-containing Uprizing 2.0 from the market. Uprizing 2.0 was sold through retail health-food stores in Alabama, Arizona, California, Georgia, Mississippi, New Jersey, South Carolina, and Texas, but also worldwide through online distributors.

According to the FDA, acute liver injury is a known possible harmful effect of using products containing synthetic anabolic steroids, such as superdrol.

“…[S]ynthetic anabolic steroids may cause…shrinkage of the testes and male infertility, masculinization of women, breast enlargement in males, short stature in children, a higher predilection to mis-use other drugs and alcohol, adverse effects on blood lipid levels, and increased risk of heart attack, stroke, and death,” the FDA said.

The FDA advises consumers who purchased Uprizing 2.0 to return it to the place of purchase. Side-effects or adverse health events suspected as being related to the taking of the ingredient superdrol should be reported to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program, the agency said.

Latest News from Pharma-Watch

FDA convenes to determine Fosamax bone fracture dangers

The New York Times Reports: In light of evidence linking the long-term use of Fosamax and femur fractures, the FDA said it plans to convene Friday to determine whether it will recommend suspending the use of the osteoporosis drug.

Spine Specialists Discredit Medtronic Bone Growth Product

June 29th, 2011 “It harms patients to have biased and corrupted research published…It harms patients to have unaccountable special interests permeate medical research,” read an excerpt from an

CT Brain Perfusion Scan Risks

The FDA released an advisory to consumers in October regarding the CT Bran Profusion Scan manufactured by GE. The advisory states that the scans default radiation therapy is set to high for most patient

Risk of death found in sleeping pill use -- Scripps

Scripps Study: Sleeping pills believed a cause of 500,000 premature deaths annually (March 1, 2012) Pick 10 people at random and ask them if they take sleeping pills. Chances are at least one of them

FDA pulls approval of Avastin breast cancer drug

Avastin no longer allowed for breast cancer The U.S. Food & Drug Administration has revoked its approval of Avastin after concluding the metastatic breast cancer treatment did nothing to control tumor